Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Adverse effects and patient information].

A Cortey1, Y Brossard

  • 1Centre National de Référence en Hémobiologie Périnatale (CNRHP), Hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|February 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[How I do…an intrauterine transfusion?]

Gynecologie, obstetrique, fertilite & senologie·2020
Same author

Intrauterine transfusions for maternofetal red-blood-cell incompatibility in monochorionic diamniotic twin pregnancy.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2019
Same author

[Blood transfusion in neonatology: Study of practical aspects in 2016 in France, excluding acute bleeding or surgical care].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2018
Same author

Maternal consumption of quinine-containing sodas may induce G6PD crises in breastfed children.

European journal of pediatrics·2017
Same author

[G6PD deficiency in females with neonatal revelation. Report of four cases].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017
Same author

[Intrauterine blood transfusion: Status report of 4years of practice in France (2011-2014)].

Journal of gynecology obstetrics and human reproduction·2017
Same journal

[Neuroprotection for preterm infants with antenatal magnesium sulphate].

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?]

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Lifestyle recommendations for prevention of spontaneous preterm birth in asymptomatic pregnant women].

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Guidelines for clinical practice: Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes) - Introduction].

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Psychological aspects of abortion].

Journal de gynecologie, obstetrique et biologie de la reproduction·2016
Same journal

[Induced abortion: Guidelines for clinical practice - Introduction].

Journal de gynecologie, obstetrique et biologie de la reproduction·2016
See all related articles

RhD negative pregnant women should receive Anti-D immunoglobulin prophylaxis after informed consent. This blood-derived product requires careful traceability and monitoring for potential effects on mothers and newborns.

Area of Science:

  • Immunology
  • Obstetrics
  • Hematology

Context:

  • Anti-D prophylaxis is crucial for RhD negative, non-sensitized pregnant women to prevent Rhesus disease.
  • Current prophylaxis involves plasma-derived anti-D immunoglobulins, necessitating adherence to safety and traceability regulations.

Purpose:

  • To outline the guidelines and considerations for administering Anti-D prophylaxis during pregnancy.
  • To inform healthcare providers about the safety, administration, and potential implications of Anti-D immunoglobulins.

Summary:

  • Prophylaxis involves informed consent and written information about Rhesus disease and anti-D immunoglobulins.
  • While generally safe, potential side effects like hemolysis and positive Direct Antiglobulin Test (DAT) in newborns are rare and manageable.

Related Experiment Videos

  • Passive anti-D can persist in maternal circulation, potentially affecting immunization diagnosis, and may cause positive DAT in newborns without clinical complications.

    • Impact:

    • Ensures appropriate management of RhD incompatibility, reducing the incidence of Rhesus disease.
    • Highlights the importance of patient education, consent, and adherence to regulatory standards for blood-derived products.
    • Provides guidance on interpreting serological findings in mothers and newborns following prophylaxis.